Cosomil Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $6.45M

  • Investors
  • 9

Cosomil General Information

Description

Developer of a liquid-based diagnostic technology designed to offer early disease diagnosis and support for drug development. The company uses single enzyme activity-based protein profile technology, which detects enzyme activity with ultra-high sensitivity at the single molecule level using fluorescent probes and microdevices, enabling the medical system to provide early and accurate diagnosis of diseases, which can lead to improved patient outcomes.

Contact Information

Website
www.cosomil.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 604, Entrepreneur Plaza, University of Tokyo
  • 7-3-1 Hongo, Bunkyo-ku
  • Tokyo, 113-0033
  • Japan
+81
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Drug Discovery
Corporate Office
  • 604, Entrepreneur Plaza, University of Tokyo
  • 7-3-1 Hongo, Bunkyo-ku
  • Tokyo, 113-0033
  • Japan
+81

Cosomil Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cosomil Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A1) 06-Feb-2026 $6.45M Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
4. Early Stage VC 29-Nov-2023 Completed Generating Revenue
3. Seed Round 01-Dec-2022 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 25-Jul-2022 Completed Startup
To view Cosomil’s complete valuation and funding history, request access »

Cosomil Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class A2
Class A1
Class A 69,635 $55.01 $55.01 1x $55.01 24.6%
To view Cosomil’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cosomil Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cosomil Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Animal Spirits Impact Investing Minority
Delight Ventures Venture Capital Minority
Gogin Capital PE/Buyout Minority
Beyond Japan Accelerator/Incubator
Coral Capital. Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Cosomil FAQs

  • When was Cosomil founded?

    Cosomil was founded in 2022.

  • Where is Cosomil headquartered?

    Cosomil is headquartered in Tokyo, Japan.

  • What is the size of Cosomil?

    Cosomil has 27 total employees.

  • What industry is Cosomil in?

    Cosomil’s primary industry is Biotechnology.

  • Is Cosomil a private or public company?

    Cosomil is a Private company.

  • What is the current valuation of Cosomil?

    The current valuation of Cosomil is .

  • What is Cosomil’s current revenue?

    The current revenue for Cosomil is .

  • How much funding has Cosomil raised over time?

    Cosomil has raised $6.45M.

  • Who are Cosomil’s investors?

    Animal Spirits, Delight Ventures, Gogin Capital, Beyond Japan, and Coral Capital. are 5 of 9 investors who have invested in Cosomil.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process